Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for March, 2011

« Older Entries

Prescription for survival

By on Thursday, March 31st, 2011 | No Comments

… goes to the brain and muscles; strontium-90 goes to bone, causing bone cancer and leukemia. It’s imperative, George, because you’re highly intelligent and a very important commentator, that you …

Read More...

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

By on Thursday, March 31st, 2011 | No Comments

Conditions :   Myelodysplastic Syndrome,;   Transfusional Iron Overload Intervention :   Drug: Deferasirox Sponsor :   Novartis Pharmaceuticals Not yet recruiting – verified March 2011

Read More...

Healthy Homes/Healthy Families

By on Thursday, March 31st, 2011 | No Comments

Condition :   Chronic Diseases Interventions :   Behavioral: Healthy Homes/Healthy Families;   Behavioral: Health Education Sponsors :   Emory University;   Centers for Disease Control and Prevention;   Southwest Georgia Cancer Coalition Enrolling by invitation – verified March 2011

Read More...

Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis

By on Thursday, March 31st, 2011 | No Comments

Condition :   Anaphylaxis Intervention :   Sponsor :   Brigham and Women’s Hospital Recruiting – verified March 2011

Read More...

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

By on Thursday, March 31st, 2011 | No Comments

Condition :   Nasopharyngeal Carcinoma Intervention :   Drug: Docetaxel, Cisplatin, 5-FU and Cetuximab Sponsors :   Hong Kong Nasopharyngeal Cancer Study Group Limited;   The University of Hong Kong;   Sanofi-Aventis;   Merck;   Roche Pharma AG Recruiting – verified March 2011

Read More...

Trial of Induction Chemotherapy (ICT) Followed by Concurrent Chemoraditherapy (CR) With Monoclonal Antibody Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

By on Thursday, March 31st, 2011 | No Comments

Condition :   Carcinoma, Squamous Cell of Head and Neck Intervention :   Other: Drug and Radiation Sponsor :   Louisiana State University - Shreveport Recruiting – verified March 2011

Read More...

Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer

By on Thursday, March 31st, 2011 | No Comments

Condition :   Carcinoma Breast Stage IV Intervention :   Drug: TRC105 Sponsors :   Tracon Pharmaceuticals Inc.;   Roswell Park Cancer Institute;   Department of Defense Not yet recruiting – verified March 2011

Read More...

Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring

By on Thursday, March 31st, 2011 | No Comments

Condition :   Carcinoma, Non-Small-Cell Lung Interventions :   Drug: Paclitaxel dosing according to SmPC;   Drug: Individualized pharmacokinetically driven paclitaxel dosing Sponsors :   Central European Society for Anticancer Drug Research;   Saladax Biomedical, Inc.;   Cantonal Hospital of St. Gallen;   University Hospital, Basel, Switzerland;   Assign data management and biostatistics Gmbh;   Wake Forest University;   University Hospital, Essen Recruiting – verified March 2011

Read More...

A Comparative Study of KW-2246

By on Thursday, March 31st, 2011 | No Comments

Condition :   Cancer Related Pain (Breakthrough Pain) Intervention :   Drug: KW-2246 Sponsor :   Kyowa Hakko Kirin Company, Limited Recruiting – verified March 2011

Read More...

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

By on Thursday, March 31st, 2011 | No Comments

Conditions :   Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Hodgkins Lymphoma;   Non-Hodgkins Lymphoma Intervention :   Sponsor :   National Cancer Institute (NCI) Recruiting – verified March 2011

Read More...
« Older Entries